Details for Patent: 10,792,246
✉ Email this page to a colleague
Which drugs does patent 10,792,246 protect, and when does it expire?
Patent 10,792,246 protects IGALMI and is included in one NDA.
This patent has twenty-three patent family members in thirteen countries.
Summary for Patent: 10,792,246
Title: | Film formulations containing dexmedetomidine and methods of producing them |
Abstract: | Disclosed herein is a self-supporting, dissolvable, film containing dexmedetomidine or a pharmaceutically acceptable salt thereof. The film is administered orally to treat various conditions, particularly agitation, by transmucosal delivery of the active agent. |
Inventor(s): | Kakumanu; Vasukumar (Guntur, IN), Hanley; David Christian (Brookfield, CT), Yocca; Frank (Clinton, CT), Lathia; Chetan Dalpatbhai (Woodbridge, CT), Barnhart; Scott David (Glen Rock, PA) |
Assignee: | BIOXCEL THERAPEUTICS, INC. (New Haven, CT) ARX, LLC (Glen Rock, PA) |
Application Number: | 16/453,679 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 10,792,246
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioxcel | IGALMI | dexmedetomidine hydrochloride | FILM;BUCCAL, SUBLINGUAL | 215390-001 | Apr 5, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ACUTE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR I OR II DISORDER BY SUBLINGUAL ADMINISTRATION | ⤷ Try a Trial | |||
Bioxcel | IGALMI | dexmedetomidine hydrochloride | FILM;BUCCAL, SUBLINGUAL | 215390-002 | Apr 5, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ACUTE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR I OR II DISORDER BY SUBLINGUAL ADMINISTRATION | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,792,246
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2019295699 | ⤷ Try a Trial | |||
Brazil | 112020026672 | ⤷ Try a Trial | |||
Canada | 3103431 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |